BroadOak Capital Partners

PBS Biotech specializes in the manufacture of single-use bioreactor systems designed to provide homogeneous and scalable mixing conditions for various cell therapy products and cell culture applications. Their bioreactors feature the smallest per liter volume footprints and are fully scalable, accommodating all stages of the cell culture process, including research and development, clinical trials, and cGMP production. In addition to their innovative bioreactor systems, PBS Biotech offers a range of process development services, including cell therapy optimization, characterization, and risk analysis. By providing efficient and cost-effective disposable systems along with expert technical services, the company helps clients address complex cell culture challenges and enhance operational efficiency in their biomanufacturing processes.

S2 Genomics, Inc. is a company based in Livermore, California, that specializes in developing advanced spatial sequencing technology. Founded in 2016, the company focuses on creating integrated sample preparation systems that automate the processing of solid tissues and liquid samples into genomic samples. This technology allows researchers to isolate single cells or nuclei from raw tissues, facilitating genomics and cell biology studies. S2 Genomics aims to streamline the preparation process, ensuring reproducibility and minimal impact on cellular transcriptomes, thereby optimizing the quantity and quality of viable cells or nuclei derived from various tissue types.

Pluristyx specializes in advanced cell therapy tools and consulting services aimed at addressing manufacturing challenges in drug development, regenerative medicine, and cell and gene therapy. The company offers a range of services, including chemistry, manufacturing, and controls (CMC) consulting, pluripotent stem cell manufacturing, and contract development and manufacturing. By providing unique products and expert consulting, Pluristyx supports and accelerates the development and commercialization of innovative therapeutics designed to treat serious human diseases. Their comprehensive approach combines specialized knowledge and practical tools to aid clients in navigating the complexities of cell and gene therapy development.

Telesis Bio is a biotech company established in 2013 and headquartered in San Diego, USA. It specializes in synthetic biology, providing researchers with tools to design, code, and create synthetic DNA and mRNA. The company focuses on enabling the rapid, accurate, and reproducible construction of high-quality synthetic genetic material for various applications in synthetic biology. Telesis Bio manufactures and sells laboratory equipment, including synthetic biology instruments, reagents, and related products. Its product offerings include the BioXp system, BioXp kits, benchtop reagents, and BioXp biofoundry services, all aimed at supporting researchers in their scientific endeavors.

Sanguine is focused on enhancing translational biomedical research by facilitating patient participation. The company offers tools and concierge services that enable patients to engage in medical research from the comfort of their homes, promoting transparency and communication throughout the process. By prioritizing respectful patient support and appropriate compensation, Sanguine aims to improve the overall patient experience and ensure that research biospecimens are more impactful. Through these efforts, Sanguine seeks to bridge the gap between patients and researchers, empowering individuals to contribute directly to the development of personalized medicines and new treatments.

CDI Labs, the result of intensive efforts and advances developed by the High-Throughput Biology Center at Johns Hopkins University, is a privately owned research and discovery company in the field of proteomics. The company was created by scientists for scientists, addressing the critical needs required in order to accelerate research, advance discoveries and translate these discoveries into novel products and services that improve human health.The company applies its accelerating platforms to internal, collaborative, and client programs.

PBS Biotech specializes in the manufacture of single-use bioreactor systems designed to provide homogeneous and scalable mixing conditions for various cell therapy products and cell culture applications. Their bioreactors feature the smallest per liter volume footprints and are fully scalable, accommodating all stages of the cell culture process, including research and development, clinical trials, and cGMP production. In addition to their innovative bioreactor systems, PBS Biotech offers a range of process development services, including cell therapy optimization, characterization, and risk analysis. By providing efficient and cost-effective disposable systems along with expert technical services, the company helps clients address complex cell culture challenges and enhance operational efficiency in their biomanufacturing processes.

Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.

seqWell Inc. is a biotechnology company that specializes in gene sequencing and laboratory services, focusing on the development of innovative library preparation technology. Founded in 2014 and based in Beverly, Massachusetts, seqWell offers a range of products and services including paramagnetic beads for nucleic acid purification, library preparation kits, and customized bioinformatics support. Its technology platform facilitates simple and scalable multiplexing of hundreds to thousands of samples, eliminating the need for time-consuming normalization processes. The company markets its products through distributors in various countries, including the United States, Australia, South Korea, and several European nations, as well as through online channels. This approach enables seqWell to enhance the efficiency and consistency of DNA sequencing workflows for its clients.

Genomenon, Inc. is a software development company based in Ann Arbor, Michigan, that specializes in tools for genetic diagnosis and discovery. Founded in 2014, it provides a suite of diagnostic and discovery solutions that enable physicians, researchers, and pharmaceutical companies to rapidly and accurately identify disease-causing variants from genomic sequencing data. The company’s flagship product, GENOMENON, automates the analysis of next-generation sequencing data, thereby enhancing decision-making processes in clinical settings and accelerating discoveries in genomics. With its focus on improving cancer diagnosis and treatment, Genomenon aims to support better patient outcomes through its innovative software solutions.

Avidien Technologies is a manufacturer of advanced liquid handling instruments designed to enhance the productivity of researchers and scientists. The company specializes in pipettes and laboratory instruments, notably its microPro 300 semi-automated 96-channel pipette, which features a wirelessly connected iPad mini interface. This innovative design allows for improved accuracy and efficiency, providing researchers with reliable and user-friendly tools. Avidien Technologies aims to deliver affordable solutions that simplify complex laboratory tasks, ultimately improving research outcomes in the scientific community.

PhenoVista Biosciences is a specialized contract research organization that focuses on high content imaging-based phenotypic assay development and screening services. The company utilizes advanced technology to conduct phenotypic screening feasibility, development, and extensive campaigns. With a team of experienced cell biologists, PhenoVista collaborates closely with clients to deliver timely and cost-effective data. The organization provides a variety of cell types and formats tailored for applications in neurobiology, oncology, metabolism, cell painting, and mitochondrial health, facilitating the development of innovative formulations and offering valuable insights into diseases using human cell models.

Accellix, Inc. is a biotechnology company focused on developing microflow cytometer systems for diagnostic applications. The company specializes in compact, tabletop flow cytometry instruments that utilize microfluidics technology, along with disposable, test-specific cartridges designed for use with these portable devices. Accellix's products provide diagnostic information for early detection of blood infections and are applicable in areas such as sepsis detection and HIV/AIDS monitoring. The company's innovations help cell and gene therapy organizations fulfill quality control requirements by offering multi-parameter results through room temperature stable cartridges. Founded in 2009 and headquartered in San Jose, California, with an additional office in Jerusalem, Accellix serves the point-of-care testing and flow cytometry markets, aiming to improve patient outcomes through accurate and efficient diagnostic solutions.

Gemini Bio-Products specializes in manufacturing biological products and chemical reagents for the global cell culture community. The company provides a variety of cell culture sera, including fetal bovine, specialized fetal bovine, as well as other non-fetal, human, and animal sera. In addition to sera, Gemini Bio-Products offers custom and specialized media, along with a range of supplements and reagents. Their product line includes amino acids, antibiotics, antimycotics, culture supplements, albumins, recombinant proteins, attachment factors, and cell dissociation reagents, catering to diverse needs within the cell culture sector.

PBS Biotech specializes in the manufacture of single-use bioreactor systems designed to provide homogeneous and scalable mixing conditions for various cell therapy products and cell culture applications. Their bioreactors feature the smallest per liter volume footprints and are fully scalable, accommodating all stages of the cell culture process, including research and development, clinical trials, and cGMP production. In addition to their innovative bioreactor systems, PBS Biotech offers a range of process development services, including cell therapy optimization, characterization, and risk analysis. By providing efficient and cost-effective disposable systems along with expert technical services, the company helps clients address complex cell culture challenges and enhance operational efficiency in their biomanufacturing processes.

KromaTiD, Inc. is an early-stage bioscience company based in Fort Collins, Colorado, established in 2007. The company specializes in chromosome analysis products aimed at advancing the understanding of genetic abnormalities and diseases. KromaTiD develops molecular cytogenetic assays and reagents, including its proprietary Directional Genomic Hybridization (dGH) technology, which enhances standard fluorescence in situ hybridization (FISH) assays. These tools enable researchers to discover, detect, and diagnose various disease-causing mutations, such as inversions and translocations, from single cells. KromaTiD’s offerings include assays for targeting entire chromosomes or individual chromatids, inversion detection solutions, and custom assays covering the entire human genome. Their products are designed to support biomedical research and medical testing applications, facilitating advancements in oncology and rare diseases, and assisting research teams in academia and the biopharma sector in developing novel therapeutics.

Genomenon, Inc. is a software development company based in Ann Arbor, Michigan, that specializes in tools for genetic diagnosis and discovery. Founded in 2014, it provides a suite of diagnostic and discovery solutions that enable physicians, researchers, and pharmaceutical companies to rapidly and accurately identify disease-causing variants from genomic sequencing data. The company’s flagship product, GENOMENON, automates the analysis of next-generation sequencing data, thereby enhancing decision-making processes in clinical settings and accelerating discoveries in genomics. With its focus on improving cancer diagnosis and treatment, Genomenon aims to support better patient outcomes through its innovative software solutions.

Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.

seqWell Inc. is a biotechnology company that specializes in gene sequencing and laboratory services, focusing on the development of innovative library preparation technology. Founded in 2014 and based in Beverly, Massachusetts, seqWell offers a range of products and services including paramagnetic beads for nucleic acid purification, library preparation kits, and customized bioinformatics support. Its technology platform facilitates simple and scalable multiplexing of hundreds to thousands of samples, eliminating the need for time-consuming normalization processes. The company markets its products through distributors in various countries, including the United States, Australia, South Korea, and several European nations, as well as through online channels. This approach enables seqWell to enhance the efficiency and consistency of DNA sequencing workflows for its clients.

InFuse Holdings operates ambulatory infusion centers that focus on delivering complex biologic infusion therapies in a safe and convenient manner. Recognizing the existing gaps in the U.S. infrastructure for infusion therapies, the company aims to improve the quality and cost-effectiveness of these services. By implementing best practices in workflow, inventory management, scheduling, safety protocols, and patient experience, InFuse Holdings creates a supportive environment for patients. This model allows the company to provide infusion services at a lower cost than traditional delivery channels, contributing to a reduction in overall healthcare expenses for patients, employers, and payers.

Codex DNA is a biology company helping researchers with the tools they need to securely design, code, and create synthetic DNA. The company is on a mission to help scientific researchers in both academic and commercial settings with the hardware, software, materials, and methodologies required to rapidly and accurately write large quantities of synthetic genes. To, in effect, build biology. Its gene synthesis portfolio reduces the turnaround time for synthesizing workflows from weeks and months to days and hours and includes the BioXp system, DNA services, Gibson Assembly reagents, and Vmax chemically competent cells. In addition to automating, speeding, and optimizing DNA design and synthesis, Codex DNA and the BioXp system ensure your designs stay in your hands, marrying speed and security for innovators in drug discovery, vaccine development, precision medicine, and beyond. Co-founded by Dan Gibson — the creator of the industry-standard Gibson Assembly methodology — Codex DNA is attempting nothing less than changing everything.

Halo Labs is a life science instrumentation company based in Burlingame, California, specializing in the development of tools for biologics researchers. Formerly known as Optofluidics, the company focuses on high throughput biopharmaceutical quality control, utilizing advanced optics, image processing, and microfluidics technologies. Halo Labs' offerings include assessment of biologics-developability, formulation development, late-stage formulation, small molecule solubility, and AAV analytics. Founded in 2011, the company has gained recognition for its innovative scientific platform, which provides critical insights into the particles involved in research processes, thereby enhancing the stability and quality assessment of biological drugs.

BioInformatics, LLC is a market research and advisory firm that serves the life science, medical device, pharmaceutical, and diagnostic industries. The company specializes in both primary and secondary research, providing insights on market size, attractiveness, and product optimization. Key services include product concept testing, pricing strategy analysis, customer satisfaction assessments, and brand strength evaluations. BioInformatics helps clients navigate corporate acquisitions and measure brand loyalty, offering tailored research that informs strategic decisions. With a multidisciplinary team of industry veterans and research experts, the firm supports clients in enhancing their market positioning and developing effective marketing strategies. Founded in 1994 and based in Arlington, Virginia, BioInformatics caters to a diverse clientele, including biotechnology firms, medical diagnostics companies, and professional service providers.

MedCision is a leader in automated cell thawing technologies for advanced therapies. The company focuses on developing and commercializing solutions that standardize and automate essential handling processes for biologics in preclinical and clinical settings. Its ThawSTAR Automated Cell Thawing Systems are designed to replace inconsistent manual thawing methods, thereby improving the safety and effectiveness of therapeutic cell thawing. These systems utilize customizable algorithms tailored to specific cell therapy products and protocols. In addition, MedCision offers ultra-low temperature storage and transport solutions, enhancing the management of temperature-sensitive biotherapeutics. By providing controlled and scalable processing capabilities, MedCision aims to improve patient outcomes and expedite recovery in healthcare settings.

LabConnect, LLC is a provider of central laboratory services tailored for the biopharmaceutical industry, medical device companies, and contract research organizations. Founded in 2002 and based in Johnson City, Tennessee, LabConnect offers a broad range of services, including routine testing in clinical chemistry, hematology, and infectious diseases, as well as specialized testing in areas such as molecular diagnostics and oncology. The company also provides pathology services, biostorage, sample tracking, and project management, alongside a Global Sample Processing Network that supports sample preparation and processing needs. LabConnect enhances its offerings with advanced technology, including the BioVisualization software platform, which allows real-time analysis of clinical sample data. With laboratories located in various regions, including the United States, Europe, and Asia, LabConnect is strategically positioned to serve both major and emerging markets in the drug development sector.

Empire Genomics, LLC is a biotechnology company specializing in molecular and cytogenetic diagnostics aimed at understanding the genetic underpinnings of diseases, particularly in oncology. Founded in 2006 and based in Buffalo, New York, with an additional office in Williamsville, the company develops advanced technologies for genome-wide analyses. Empire Genomics offers a range of products, including fluorescence in situ hybridization (FISH) probes, bacterial artificial chromosomes (BAC) clones, and various clinical testing services that encompass flow cytometry, cytogenetics, and next-generation sequencing (NGS). Its comprehensive assay services support healthcare providers in diagnosing and guiding precise therapeutic treatments for patients with cancer and other complex diseases. The company also emphasizes customer support and has established strategic partnerships with notable organizations in the industry. Through its online store and global distribution network, Empire Genomics delivers its innovative solutions to customers worldwide.

Rubicon Genomics, Inc. is a biotechnology company based in Ann Arbor, Michigan, focused on developing nucleic acid library preparation and amplification technologies. Founded in 2000 by two faculty members from the University of Michigan, the company aims to translate human genetics research into practical medical applications. Rubicon offers a range of products, including the ThruPLEX and PicoPLEX series, which provide high sensitivity ligation-based and quasi-random primed amplification solutions for analyzing clinical research samples. These products are designed to improve the detection of DNA methylation patterns in cancer cells and facilitate non-invasive diagnostic tests by amplifying small amounts of abnormally methylated DNA found in bodily fluids. Rubicon sells its products through distributors and its online platforms, maintaining a commitment to supporting the Michigan economy while establishing itself as a leader in pre-analytical amplification technologies.

Diagnostic BioSystems Inc. specializes in enhancing immunohistochemistry results by offering innovative anatomic pathology reagents and systems. The company focuses on providing high-quality products and exceptional customer service. It serves the anatomic pathology and histology markets through direct sales in the domestic market and via international distributors in over 60 countries. Diagnostic BioSystems' product portfolio includes primary and FITC antibodies, autostainers, chromogens, detection kits, and various ancillary products, all designed to support the practice of pathology and improve diagnostic accuracy. Additionally, the company manufactures medical devices to complement its offerings.

Azenta Life Sciences specializes in providing comprehensive life sciences services, focusing on genomics, cryogenic storage, automation, and informatics. The company delivers a reliable suite of cold-chain sample management solutions and genomic services tailored for drug development, clinical research, and advanced cell therapies. Its clientele includes leading pharmaceutical, biotech, academic, and healthcare institutions worldwide. Azenta operates through two main segments: Life Sciences Products and Life Sciences Services, with a significant portion of its revenue derived from the services segment. By enabling impactful breakthroughs, Azenta aims to accelerate the delivery of innovative therapies to the market.